Thermo Fisher Scientific made another big move in life sciences at the end of 2021, paying $1.85 billion to buy the recombinant protein maker PeproTech. New Jersey–based PeproTech provides cytokines, ...
Thermo Fisher Scientific Inc. TMO recently announced the completion of its PeproTech buyout on December 30, 2021 for a total cash consideration of around $1.85 billion. The acquisition is set to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results